**Question:** Abzyme is an

A. Enzyme
B. Antibody
C. Peptide
D. Protein

**Correct Answer:** B. Antibody

**Core Concept:** Abzyme refers to a biologic molecule that exhibits enzymatic activity, typically involving a fusion of an enzyme with a monoclonal antibody or another protein. These molecules can be engineered to target specific antigens (biomolecules that are recognized as foreign by the immune system).

**Why the Correct Answer is Right:** An antibody, also known as an immunoglobulin, is a protein produced by the immune system in response to an antigen. Antibodies are Y-shaped molecules that can bind to specific antigens, marking them for destruction by other immune cells. In the context of abzymes, antibodies are used as targeting vectors to deliver enzymes to specific cells or tissues.

**Why Each Wrong Option is Incorrect:**

A. Enzyme (Option A): Enzymes are proteins that act as biological catalysts, speeding up chemical reactions within cells. They are not designed for targeting specific cells or tissues, unlike abzymes.

C. Peptide (Option C): A peptide is a short chain of amino acids, not a biologic molecule with targeting capabilities like abzymes.

D. Protein (Option D): Similar to enzyme, proteins are macromolecules with diverse functions in cells. They do not possess targeting capabilities as seen in abzymes.

**Clinical Pearl:** Abzymes offer a unique approach in targeted therapy, enabling selective drug delivery to diseased cells or tissues. This concept has implications in cancer therapy, where enzymes can be fused to antibodies to selectively degrade tumor vasculature or inhibit tumor cell growth.

By understanding the correct answer (antibody) and the wrong options (enzyme, peptide, and protein), medical students should recognize the specificity and targeting potential of abzymes, which is crucial in the field of biotherapeutics and personalized medicine.